Medicine & Life Sciences

1. Multiple Myeloma 100%
2. Fluorescence In Situ Hybridization 98%
3. Gene Fusion 73%
4. Precursor Cell Lymphoblastic Leukemia-Lymphoma 70%
5. High-Throughput Nucleotide Sequencing 51%
6. Cytogenetics 51%
7. Acute Myeloid Leukemia 45%
8. Hematologic Neoplasms 37%
9. Chromosomes 36%
10. Chromosome Aberrations 29%
11. Plasma Cells 29%
12. Proteasome Inhibitors 28%
13. Genes 24%
14. Bortezomib 24%
15. Pediatrics 23%
16. Neoplasms 21%
17. Mantle-Cell Lymphoma 18%
18. B-Lymphocytes 17%
19. Clone Cells 17%
20. Leukemia 16%
21. Protein-Tyrosine Kinases 15%
22. Core Binding Factors 15%
23. Cyclin-Dependent Kinase 6 14%
24. Technology 14%
25. Metaphase 14%
26. Survival 14%
27. Cyclin-Dependent Kinase 4 13%
28. Genomics 13%
29. Therapeutics 13%
30. Abelson murine leukemia virus 13%
31. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12%
32. Gene Rearrangement 12%
33. Cyclin D1 12%
34. Acute Promyelocytic Leukemia 12%
35. Young Adult 11%
36. Trisomy 11%
37. Color 11%
38. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11%
39. Bone Marrow 10%
40. Bone Marrow Cells 10%
41. Cell Line 10%
42. Eosinophilia 10%
43. Plasma Cell Neoplasms 9%
44. Immunoglobulin Genes 9%
45. Genome 9%
46. Type I Trichorhinophalangeal Syndrome 9%
47. AICDA (activation-induced cytidine deaminase) 9%
48. Gene Expression Profiling 9%
49. Chromosome Banding 9%
50. hydroxyacylglutathione hydrolase 8%